Litcius/Paper detail

Role of PRKDC in cancer initiation, progression, and treatment

Yu Chen, Yi Li, Jiani Xiong, Bin Lan, Xuefeng Wang, Jun Li, Jing Lin, Zhaodong Fei, Xiaobin Zheng, Chuanben Chen

2021Cancer Cell International48 citationsDOIOpen Access PDF

Abstract

The PRKDC gene encodes the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) protein. DNA-PKcs plays an important role in nonhomologous end joining (NHEJ) of DNA double-strand breaks (DSBs) and is also closely related to the establishment of central immune tolerance and the maintenance of chromosome stability. The occurrence and development of different types of tumors and the results of their treatment are also influenced by DNA-PKcs, and it may also predict the results of radiotherapy, chemotherapy, and therapy with immune checkpoint inhibitors (ICIs). Here, we discuss and review the structure and mechanism of action of PRKDC and DNA-PKcs and their relationship with cancer.

Topics & Concepts

DNA-PKcsDNACancer researchImmune systemGeneCancerBiologyChromosomeProtein subunitDNA repairProtein kinase AKinaseMedicineCell biologyGeneticsDNA Repair MechanismsCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapy
Role of PRKDC in cancer initiation, progression, and treatment | Litcius